Please Wait.....
Report
North America Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
Market Report I 2023-01-10 I 127 Pages I The Insight Partners
The North America influenza vaccines market is expected to grow from US$ 3,155.29 million in 2022 to US$ 4,909.00 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2022 to 2028.
Increase in Government Support to Promote Influenza Vaccination Boosts North America Influenza Vaccines Market
Several governments of North American countries are supporting the promotion of vaccination through multiple activities and programs. By 2022, enough vaccines have been secured to cover all risk groups eligible for a government-funded flu vaccine through the National Immunisation Program (NIP). A few more instances of government support for influenza vaccination include: In July 2022, Public Services and Procurement Minister Filomena Tassi and Health Minister Jean-Yves Duclos announced that the Government of Canada had signed a new contract with GlaxoSmithKline (GSK) to support a sustainable influenza pandemic readiness. The Government of Canada maintains pandemic influenza vaccine preparedness in the event of an influenza pandemic. It has had a contract with GSK to provide seasonal and pandemic influenza vaccines since 2001. Pandemic influenzas are unpredictable but occur when a new strain of influenza virus emerges, spreads widely, and causes the disease. In July 2022, Seniors and Long-term Care Minister Scott Johnston and Health Minister Audrey Gordon announced that the Manitoba government would expand the high-dose flu vaccine eligibility to include all adults aged 65 and over to ensure that more of the Manitoba population is protected against influenza. The Victorian government proposed a grant and reimbursement program to help GPs and pharmacies improve access and uptake of the influenza vaccines by June and July 2022. In September 2019, the former US President Donald Trump signed an executive order to promote the development of better vaccines against seasonal flu and the potential for pandemic flu outbreaks. In October 2021, the Provincial Government encouraged all Newfoundlanders and Labradorians to get a flu shot. From October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. Thus, increasing government support to promote the influenza vaccination is driving the North America influenza vaccines market.
North America Influenza Vaccines Market Overview
The North America influenza vaccines market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2022. The rising number of flu cases, growing research & development activities on flu vaccines, and increasing demand for advanced vaccines to prevent diseases are among the prominent factors propelling the market growth in this region.
North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
North America Influenza Vaccines Market Segmentation
The North America influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.
Based on vaccine type, the North America influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.
Based on virus type, the North America influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.
Based on technology, the North America influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.
Based on route of administration, the North America influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.
Based on target group, the North America influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.
Based on country, the North America influenza vaccines market is segmented into the US, Mexico, and Canada. The US dominated the market in 2022.
AstraZeneca; Emergent BioSolutions Inc.; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; Moderna, Inc.; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the North America influenza vaccines market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Influenza Vaccines Market - By Vaccine Type
1.3.2 North America Influenza Vaccines Market - By Virus Type
1.3.3 North America Influenza Vaccines Market - By Technology
1.3.4 North America Influenza Vaccines Market - By Route of Administration
1.3.5 North America Influenza Vaccines Market - By Target Group
1.3.6 North America Influenza Vaccines Market - By Country
2. North America Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Influenza Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Influenza Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market -North America Analysis
6.1 North America Influenza Vaccines Market, By Country - Forecasts And Analysis
6.2 North America Influenza Vaccines Market Revenue Forecasts And Analysis - 2020- 2028 (US$ Mn)
6.2.1 North America: Influenza Vaccines Market, 2019-2028 (US$ Million)
7. North America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type
7.1 Overview
7.2 North America Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.2.1 North America: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Quadrivalent Vaccines : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Trivalent Vaccines : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type
8.1 Overview
8.2 North America Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.2.1 North America: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology
9.1 Overview
9.2 North America Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.2.1 North America: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
9.3 Egg-based
9.3.1 Overview
9.3.2 Egg-based : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Cell-Based : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration
10.1 Overview
10.2 North America Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.2.1 North America: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
10.3 Injection
10.3.1 Overview
10.3.2 Injection : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Nasal Spray: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. North America Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group
11.1 Overview
11.2 North America Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.2.1 North America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
11.3 Infants
11.3.1 Overview
11.3.2 Infants : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Children: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Adults : North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Elderly People: North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. North America Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis
12.1 North America Influenza Vaccines Market Revenue and Forecasts To 2028
12.1.1 Overview
12.1.2 North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.1.2.1 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 US: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.1.4 US: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.1.5 US: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.1.6 US: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.1.7 US: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 Canada: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.2.4 Canada: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.2.5 Canada: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.2.6 Canada: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.2.7 Canada: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.2.3 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 Mexico: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
12.1.2.3.4 Mexico: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
12.1.2.3.5 Mexico: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
12.1.2.3.6 Mexico: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.2.3.7 Mexico: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
13. North America Influenza Vaccine Market -Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Moderna, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 SEQIRUS
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Emergent BioSolutions Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Mitsubishi Chemical Group Corporation
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Serum Institute of India Pvt. Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 MYLAN N.V.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AstraZeneca
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Below are a few instances of companies and their pipeline products:
Table 2. North America Influenza Vaccines Market- Revenue and Forecast to 2028 (USD Million)
Table 3. North America Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 6. North America Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
Table 7. North America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 8. US Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. US Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. US Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 11. US Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 12. US Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 13. Canada Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 23. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 24. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 25. Glossary of Terms, Influenza Vaccines Market
LIST OF FIGURES
Figure 1. North America Influenza Vaccines Market Segmentation
Figure 2. North America Influenza Vaccines Market Segmentation, by Country
Figure 3. North America Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in North America Influenza Vaccines Market
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 9. North America Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 10. Quadrivalent Vaccines: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Trivalent Vaccines: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 13. Influenza Virus Type A : North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Influenza Virus Type B: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 16. Egg-based: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Cell-Based: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 19. Injection: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Nasal Spray: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 22. Infants: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Children: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Adults: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Elderly People: North America Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. North America: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 28. US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Growth Strategies in the Influenza Vaccine Market, 2021-2028
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security